Local Institution

Bruges B-8000

0 studies enrolling now · 10 studies all time

What they study most

Acute Coronary Syndrome, Acute Coronary Syndrome (ACS), Atrial Fibrillation, Atrial Flutter, Chronic Myeloid Leukemia, HIV Infections, Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Lung Cancer - Non Small Cell, Myeloid Leukemia, Chronic, Myeloid Leukemia, Chronic, Accelerated Phase, Myeloid Leukemia, Chronic, Chronic-Phase

Studies at this site

• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923) — Stopped early
• A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia — Completed
• Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Safety Study of Apixaban in Recent Acute Coronary Syndrome — Completed
• Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML — Completed
• Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer — Stopped early
• BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada — Completed
• Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia — Completed